Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2b dose-ranging trial of topical delgocitinib cream in chronic hand eczema
2018-000900-40Phase 2Completed
- Sponsor
- LEO Pharma
- Start
- Oct 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of delgocitinib in chronic hand dermatitis (CHE) (5 arms), sponsored by LEO Pharma. Started Oct 2018; status: completed.
02
Drugs
delgocitinib
03
Conditions
chronic hand dermatitis (CHE)
Beyond the preview
Go deeper on 2018-000900-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-000900-40.